Digital

New and emerging treatments in psychiatry – 17 & 18 June

Mental healthcare

Course information

Upcoming Date: 17/06/2021
Upcoming Time: 09:00 - 16:45
Book now
More info... View speakers
Length: 2 Days
Cost: £299.00
Equivalent to 12 CPD hours

About the course

new and emerging treatments in psychiatry

As our understanding of the causes of mental illness has developed, a growing number of pharmacological and non-pharmacological interventions have shown potential as novel treatments. While some of these remain experimental, others are emerging into routine clinical practice in the UK and around the world.

Drawing on recent exciting research findings, many of these interventions shine a new light on the causes and pathologies associated with psychiatric illnesses and are paving the way towards the future of psychiatry. From psychedelics to gut microbiome, this two-day course will introduce clinicians to the major new interventions with strong or promising clinical evidence. Learners will become familiar with the sorts of treatments currently available through either clinical or research pathways and be able to recommend these to their patients where appropriate. Each session will be taught by well-known academic and clinical experts from the IoPPN/Maudsley who work at the frontier of mental health research including Prof Allan Young (KCL Chair of Mood Disorders) and Prof David Veale (director of the Maudsley national service for OCD and related disorders).

This course will cover topics such as psilocybin, ketamine, MDMA, cannabis, transcranial magnetic stimulation, triple chronotherapy, and gut microbiome.

An interview with Dr James Rucker:


 

 

 

 

 

Course presented by

Click on the speaker's profile to find out more

A group of people standing in a circle with their hands in the middle.

Learning Objectives

After taking this course participants will be able to:

  • Describe a variety of emerging novel pharmacological and non-pharmacological treatments in psychiatry
  • Identify scientific and clinical evidence base supporting the major emerging treatments in psychiatry
  • Determine whether some novel treatments may be appropriate for their patients
  • Signpost patients to service or research programs that provide novel treatments

Course Information

Target audience

Academic, Assistant psychologist, Clinical psychologist, Consultant – non-psychiatry any, Consultant – psychiatry, CT1-3 – non-psychiatry any, CT1-3 – psychiatry, FY1, FY2, FY3, GP, GPVTS, Medical student, Occupational therapist, Psychology student, RMN, ST4-7 – non-psychiatry any, ST4-7 – psychiatry

Book this course

£399.00 £299.00

Related Courses

See more of our popular courses

View All

The fusion of Education and the Health Service is extremely exciting and now indeed essential; I am thrilled that St Mary’s is at the forefront of this. I am truly invigorated to disseminate many nuggets of wisdom and tangible strategies gained yesterday to my entire school community.
Assistant Headteacher - London
The knowledge and skills help children in many areas e.g. friendships, learning, attitude, dealing with problems at home and school. Skills will stay with them as they progress helping them to be reflective and emotionally resilient.
Teacher - London